Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational studyAndrew Ip, Stuart L. Goldberg, Noa Biran et al.|PLoS ONE|2020Cited by 144
Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients – An Observational StudyAndrew Ip, Stuart L. Goldberg, Donald A. Berry et al.|medRxiv|2020Cited by 69
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Paolo Strati, Allison Rosenthal et al.|Blood Advances|2022Cited by 37
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19Donald A. Berry, Stuart L. Goldberg, Andrew Ip et al.|PLoS ONE|2021Cited by 9
A Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell TherapySushanth Gouni, Paolo Strati, Allison Rosenthal et al.|Blood|2021Cited by 1